Jens Cardinale

8PUBLICATIONS
21CO-AUTHORS
Molecular targetsGene and molecular therapyAcceleratorsPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 28, 2025
Pretargeting: Bridging the Two Worlds of Radiopharmaceutical Probes.

Yuriko Mori, Jens Cardinale, Frederik L Giesel

|Nov 27, 2024
Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Kentaro Hisada, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami

|Jun 19, 2024
Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer.

Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga

|Jan 23, 2024
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga

|May 27, 2023
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.

Ayaka Aso, Hinako Nabetani, Yoshifumi Matsuura

|Jan 03, 2023
FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

Yuriko Mori, Katharina Dendl, Jens Cardinale

Pageof 2

Frequent Collaborators

4 joint publications

Koichi Fukase

4 joint publications

Kazuko Kaneda-Nakashima

4 joint publications

Yoshifumi Shirakami

3 joint publications

Tadashi Watabe